BioReference Laboratories, Elmwood Park, NJ, an OPKO Health company, announced a covid-19 testing agreement for players and staff, stadium employees, and league staff for the 2021 Major League Baseball (MLB) season.
Under the agreement with MLB, BioReference will provide on-site rapid PCR point-of-care covid-19 testing to all 30 MLB teams, leveraging Mesa Biotech’s Accula System. Testing will continue throughout the season.
“With this announcement, BioReference is now supporting all five major professional men’s sports leagues in the United States in safely moving forward with their seasons,” says Jon R. Cohen, MD, executive chairman of BioReference Laboratories. “BioReference is proud to provide covid-19 solutions to help ensure the return to a safe, full MLB season in 2021. MLB and our other sports league clients have continued to demonstrate exemplary commitment to the health and safety of their players, employees, and stadium staff throughout the pandemic.”
“We’re excited to be partnering with BioReference and look forward to their help in bringing baseball back in 2021. Safety is our top priority, and we’re committed to making sure that our Clubs across the country are able to play a full season and that everyone involved stays healthy,” says Jon Coyles, vice president of drug, health and safety programs at the Office of the Commissioner of Baseball. “We’re ready for a great season. Play ball!”For more information, visit BioReference Laboratories.